Caitong International Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3K Buy
223
+213
+2,130% +$10.1K ﹤0.01% 1061
2025
Q4
$374 Sell
10
-300
-97% -$12.2K ﹤0.01% 1520
2025
Q3
$12.5K Buy
310
+175
+130% +$5.78K 0.01% 940
2025
Q2
$3.45K Sell
135
-39
-22% -$850 ﹤0.01% 1177
2025
Q1
$3.72K Buy
+174
New +$3.89K ﹤0.01% 1109

Other funds holding PAHC

Caitong International Asset Management's PAHC Position: Q1 2026 in Review

Caitong International Asset Management increased its Phibro Animal Health (PAHC) stake by 2,130% in Q1 2026, buying an estimated $10.1K and bringing the position to 223 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Caitong International Asset Management first reported a position in PAHC in Q1 2025 and has held it in 5 quarters since. The position peaked at $12.5K in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Caitong International Asset Management held 223 shares of Phibro Animal Health worth $12.3K as of Q1 2026.
  • Caitong International Asset Management bought 213 Phibro Animal Health shares in Q1 2026, an estimated $10.1K.
  • Phibro Animal Health made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1061 holding.
  • Caitong International Asset Management first reported a position in Phibro Animal Health in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Phibro Animal Health position peaked at $12.5K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.